Histological processes in HCM Four histological processes in hypertrophic cardiomyopathy (HCM): Myocyte hypertrophy Myocyte and myofibrillar disarray Small vessel disease Fibrosis Reference McKenna WJ, Moon JC, Sulaiman A.
Diagnostic criteria for peripartum cardiomyopathy Diagnostic criteria for peripartum cardiomyopathy are: Development of heart failure in the last month of pregnancy or within 5 months after delivery Left
SGLT2 inhibitors and GLP-1 receptor agonists for diabetics with heart failure Sodium glucose cotransporter 2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) are two new promising
Extreme high high-density lipoprotein (HDL) cholesterol may paradoxically increase risk Usually, high-density lipoprotein (HDL) cholesterol concentrations are inversely associated with cardiovascular disease and mortality. But there is some
Antibiotic effect of ticagrelor Ticagrelor is a reversible platelet adenosine diphosphate P2Y12 receptor (P2Y12) inhibitor and is quite effective as an antiplatelet agent. New research suggests an antibiotic
Ticagrelor vs other P2Y12 inhibitors Ticagrelor is a reversible P2Y12 receptor inhibitor whereas clopidogrel and prasugrel are irreversible inhibitors. Ticagrelor does not require metabolic activation, absorption is rapid